Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01656733 · ClinicalTrials.gov registry record · Phase 4
Nicotine Replacement for Smoking Cessation During Pregnancy
A Phase 4 study, sponsored by UConn Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 154
- Enrollment target
NCT01656733 is a Phase 4 study that has completed, run by UConn Health. The registered enrollment target is 154 participants.
The verdict
NCT01656733, a Phase 4 study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 154 participants
- Enrollment target
Study Summary
This is a clinical trial to determine if the nicotine inhaler in combination with counseling will help pregnant women quit smoking, and whether it is safe when compared to placebo (an inactive inhaler).
Interventions
- DRUG Placebo Inhaler
- DRUG Nicotrol Inhaler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2012-08 |
| Est. Completion | 2017-10-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01656733
The ClinicalTrials.gov registry entry for NCT01656733 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Inhaler is the first listed.
NCT01656733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01656733 about?
NCT01656733 is a clinical study titled "Nicotine Replacement for Smoking Cessation During Pregnancy". This is a clinical trial to determine if the nicotine inhaler in combination with counseling will help pregnant women quit smoking, and whether it is safe when compared to placebo (an inactive inhaler).
What is the current status of trial NCT01656733?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 154 participants. The study started on 2012-08. Estimated completion is 2017-10-25.
What interventions are being tested in trial NCT01656733?
The interventions under investigation include: Placebo Inhaler (DRUG), Nicotrol Inhaler (DRUG).
Who is sponsoring clinical trial NCT01656733?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.